Clinical Trials Browser

Phase NA × Docetaxel × Tumor-Agnostic × Clear all

NCT01295086 2020-11-02

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Phase NA Completed

Adenocarcinoma